Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delia, D
Right arrow Articles by Pierotti, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delia, D
Right arrow Articles by Pierotti, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Regulation of apoptosis induced by the retinoid N-(4-hydroxyphenyl) retinamide and effect of deregulated bcl-2

D Delia, A Aiello, F Formelli, E Fontanella, A Costa, T Miyashita, JC Reed and MA Pierotti

Istituto Nazionale Tumori, European Institute of Oncology, Milan, Italy.

The cancer chemopreventive retinoid N-(4-hydroxyphenyl)-all-trans retinamide (HPR) was recently shown by us to have antiproliferative and apoptotic effects on human leukemic cell lines, including those unresponsive to all-trans retinoic acid (ATRA). We have now characterized further the process of HPR-induced cell death. We report that inhibitors of RNA transcription and of protein synthesis, activators of protein kinase C (PKC), inhibitors of tyrosine kinases, Zn++, and the antioxidants acetylcysteine, ascorbic acid, alpha- tocopherol, and deferoxamine suppressed HPR-induced apoptosis. HL60 cells induced toward monocytic differentiation by 1,25 dihydroxyvitamin- D3 [1,25(OH)2D3], but not those induced toward the granulocytic differentiation by ATRA, showed reduced responses to HPR. The transport of HPR by cells with different sensitivity to the retinoid, however, was similar, even after treatment with the phorbol ester 12-O- tetradecanoylphorbol-13-acetate (TPA), which induces unresponsiveness to HPR. The expression of the apoptosis-related genes bcl-2, p53, and c- myc was examined to determine their role in HPR-triggered cell death. The levels of bcl-2 mRNA were markedly diminished by 24 hours of HPR treatment in all cell lines except in the relatively HPR-insensitive line K422. However, probably because of its long half-life, bcl-2 protein levels were either unchanged or only slightly decreased. Downregulation of p53 mRNA was also observed within 24 hours of HPR exposure in NB4 but not K422 cells, but no changes in the amount of p53 protein were found. Suppression of c-myc transcription was observed in all cells except K422. The protective role of bcl-2 on cell death by HPR was investigated in HL60 as well as 697 pre-B leukemia and Jurkat T- acute lymphocytic leukemia (T-ALL) cells constitutively expressing high levels of bcl-2 proteins due to gene transfer manipulation. Compared with control cells, the onset of apoptosis in these cells with deregulated bcl-2 production was delayed by at least 24 hours. These findings establish that cell death by HPR requires RNA transcription and protein synthesis and is regulated by the activation of PKC. Although changes in bcl-2, p53, and c-myc expression are found in cells treated with HPR, the time-course of these events suggests that HPR- triggered apoptosis is not directly controlled by these genes. Finally, while ectopic overexpression of bcl-2 does not protect cells from death by HPR, it markedly delays its onset.(ABSTRACT TRUNCATED AT 400 WORDS)

Volume 85, Issue 2, pp. 359-367, 01/15/1995
Copyright © 1995 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
H.-J. Chiu, D. A. Fischman, and U. Hammerling
Vitamin A depletion causes oxidative stress, mitochondrial dysfunction, and PARP-1-dependent energy deprivation
FASEB J, November 1, 2008; 22(11): 3878 - 3887.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. J. Maurer, O. Kalous, D. W. Yesair, X. Wu, J. Janeba, V. Maldonado, V. Khankaldyyan, T. Frgala, B.-C. Sun, R. T. McKee, et al.
Improved Oral Delivery of N-(4-Hydroxyphenyl)Retinamide with a Novel LYM-X-SORB Organized Lipid Complex
Clin. Cancer Res., May 15, 2007; 13(10): 3079 - 3086.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. P. Schroeder, H. Kadara, D. Lotan, J. K. Woo, H.-Y. Lee, W. K. Hong, and R. Lotan
Involvement of Mitochondrial and Akt Signaling Pathways in Augmented Apoptosis Induced by a Combination of Low Doses of Celecoxib and N-(4-Hydroxyphenyl) Retinamide in Premalignant Human Bronchial Epithelial Cells
Cancer Res., October 1, 2006; 66(19): 9762 - 9770.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. G. Villani, V. Appierto, E. Cavadini, A. Bettiga, A. Prinetti, M. Clagett-Dame, R. W. Curley, and F. Formelli
4-Oxo-Fenretinide, a Recently Identified Fenretinide Metabolite, Induces Marked G2-M Cell Cycle Arrest and Apoptosis in Fenretinide-Sensitive and Fenretinide-Resistant Cell Lines.
Cancer Res., March 15, 2006; 66(6): 3238 - 3247.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Shishodia, A. M. Gutierrez, R. Lotan, and B. B. Aggarwal
N-(4-Hydroxyphenyl)Retinamide Inhibits Invasion, Suppresses Osteoclastogenesis, and Potentiates Apoptosis through Down-regulation of I{kappa}B{alpha} Kinase and Nuclear Factor-{kappa}B-Regulated Gene Products
Cancer Res., October 15, 2005; 65(20): 9555 - 9565.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Nencioni, L. Wille, G. Dal Bello, D. Boy, G. Cirmena, S. Wesselborg, C. Belka, P. Brossart, F. Patrone, and A. Ballestrero
Cooperative Cytotoxicity of Proteasome Inhibitors and Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Chemoresistant Bcl-2-Overexpressing Cells
Clin. Cancer Res., June 1, 2005; 11(11): 4259 - 4265.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Sherrill, M. P. Byrd, M. E. Van Eden, and R. E. Lloyd
BCL-2 Translation Is Mediated via Internal Ribosome Entry during Cell Stress
J. Biol. Chem., July 9, 2004; 279(28): 29066 - 29074.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. K. Gopal, J. M. Pagel, N. Hedin, and O. W. Press
Fenretinide enhances rituximab-induced cytotoxicity against B-cell lymphoma xenografts through a caspase-dependent mechanism
Blood, May 1, 2004; 103(9): 3516 - 3520.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Pirkmaier, K. Yuen, J. Hendley, M. J. O'Connell, and D. Germain
Cyclin D1 Overexpression Sensitizes Breast Cancer Cells to Fenretinide
Clin. Cancer Res., May 1, 2003; 9(5): 1877 - 1884.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Erdreich-Epstein, L. B. Tran, N. N. Bowman, H. Wang, M. C. Cabot, D. L. Durden, J. Vlckova, C. P. Reynolds, M. F. Stins, S. Groshen, et al.
Ceramide Signaling in Fenretinide-induced Endothelial Cell Apoptosis
J. Biol. Chem., December 13, 2002; 277(51): 49531 - 49537.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K.-R. You, J. Wen, S.-T. Lee, and D.-G. Kim
Cytochrome c Oxidase Subunit III. A MOLECULAR MARKER FOR N-(4-HYDROXYPHENYL)RETINAMIDE-INDUCED OXIDATIVE STRESS IN HEPATOMA CELLS
J. Biol. Chem., February 1, 2002; 277(6): 3870 - 3877.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. Shan, A. K. Gopal, and O. W. Press
Synergistic Effects of the Fenretinide (4-HPR) and Anti-CD20 Monoclonal Antibodies on Apoptosis Induction of Malignant Human B Cells
Clin. Cancer Res., August 1, 2001; 7(8): 2490 - 2495.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
I. Ponzanelli, M. Gianni, R. Giavazzi, A. Garofalo, I. Nicoletti, U. Reichert, E. Erba, A. Rambaldi, M. Terao, and E. Garattini
Isolation and characterization of an acute promyelocytic leukemia cell line selectively resistant to the novel antileukemic and apoptogenic retinoid 6-[3-adamantyl-4-hydroxyphenyl]-2-naphthalene carboxylic acid
Blood, April 15, 2000; 95(8): 2672 - 2682.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. C. Reed
Fenretinide: the Death of a Tumor Cell
J Natl Cancer Inst, July 7, 1999; 91(13): 1099 - 1100.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
B. J. Maurer, L. S. Metelitsa, R. C. Seeger, M. C. Cabot, and C. P. Reynolds
Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N-(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines
J Natl Cancer Inst, July 7, 1999; 91(13): 1138 - 1146.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Monczak, M. Trudel, W. W. Lamph, and W. H. Miller Jr
Induction of Apoptosis Without Differentiation by Retinoic Acid in PLB-985 Cells Requires the Activation of Both RAR and RXR
Blood, November 1, 1997; 90(9): 3345 - 3355.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. N. Fanjul, D. Delia, M. A. Pierotti, D. Rideout, J. Qiu, and M. Pfahl
4-Hydroxyphenyl Retinamide Is a Highly Selective Activator of Retinoid Receptors
J. Biol. Chem., September 13, 1996; 271(37): 22441 - 22446.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Nishikawa, B. I. Carr, M. Wang, S. Kar, F. Finn, P. Dowd, Z. B. Zheng, J. Kerns, and S. Naganathan
Growth Inhibition of Hepatoma Cells Induced by Vitamin K and Its Analogs
J. Biol. Chem., November 24, 1995; 270(47): 28304 - 28310.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1995 by American Society of Hematology         Online ISSN: 1528-0020